Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
468 Cards in this Set
- Front
- Back
Pregnant woman in 3rd trimester
has normal blood pressure when standing and sitting. When supine, blood pressure drops to 90/50. |
Compression of the IVC.
|
|
35-year-old man has high blood
pressure in his arms and low pressure in his legs. |
Coarctation of the aorta.
|
|
5-year-old boy presents with
systolic murmur and wide, fixed split S2. |
ASD.
|
|
During a game, a young
football player collapses and dies immediately. |
Hypertrophic cardiomyopathy.
|
|
Patient has a stroke after
incurring multiple long bone fractures in trauma stemming from a motor vehicle accident. |
Fat emboli.
|
|
Elderly woman presents with a
headache and jaw pain. Labs show elevated ESR. |
Temporal arteritis.
|
|
80-year-old man presents with a
systolic crescendo-decrescendo murmur. |
Aortic stenosis.
|
|
Man starts a medication for
hyperlipidemia. He then develops a rash, pruritus, and GI upset. |
Niacin.
|
|
Patient develops a cough and
must discontinue captopril. name good altenatives |
Losartan, an angiotensin II
receptor antagonist, does not ↑ bradykinin as captopril does. |
|
Carotid sheath structures
|
3 structures inside: VAN.
1. Internal jugular Vein (lateral) 2. Common carotid Artery (medial) 3. Vagus Nerve (posterior) |
|
location of
Internal jugular Vein (lateral) Common carotid Artery (medial) Vagus Nerve (posterior) |
Carotid sheath
|
|
In the majority of cases, the SA
and AV nodes are supplied by |
the RCA.
|
|
what supplies
the inferior portion of the left ventricle |
80% of the time the RCA supplies
via the PD = right dominant). |
|
Coronary artery
names |
Acute marginal artery
Left main coronary artery (LCA) Circumflex artery (CFX) Left anterior descending artery (LAD) Posterior descending artery (PD) Right coronary artery (RCA) |
|
artery (= right dominant).
Coronary artery occlusion occurs most commonly in and supplies what? |
the LAD, which supplies
the anterior interventricular septum. |
|
The most posterior part of the
heart is what and implications |
left atrium;
enlargement can cause dysphagia. |
|
Where to listen to the Heart
|
APTM
aortic: Right 2ndICS Pulmonic:left 2ndICS Tricuspid: left 4th ICS Mitral: left 5th ICS lateral to left midclavicular line |
|
What is heard best at
Aortic area: |
Systolic murmur
• Aortic stenosis • Flow murmur |
|
What is heard best at
Left sternal border: |
Diastolic murmur
• Aortic regurgitation • Pulmonic regurgiation |
|
What is heard best at
Pulmonic area: |
Diastolic murmur
• Pulmonic stenosis • Flow murmur |
|
What is heard best at
Tricuspid area: |
Pansystolic murmur
• Tricuspid regurgitation • Ventricular septal defect Diastolic murmur • Tricuspid stenosis • Atrial septal defect |
|
What is heard best at
Mitral area: |
Systolic murmur
• Mitral regurgitation Diastolic murmur • Mitrial stenosis |
|
Cardiac output (CO)=
|
= (stroke volume) × (heart rate).
|
|
CO in During exercise, CO ↑
initially as a result of an ↑ in SV. After prolonged exercise, CO ↑ as a result of an ↑ in HR. |
CO ↑
initially as a result of an ↑ in SV. After prolonged exercise, CO ↑ as a result of an ↑ in HR. |
|
fick principle
|
CO = rate of O2 consumption/
(arterial O2 content-venous O2 content) |
|
Mean arterial pressure =
= (cardiac output) × (total peripheral resistance) |
MAP = (co) × (TPR)
MAP = 2/3 diastolic + 1/3 systolic |
|
Pulse pressure =
|
systolic - diastolic
and is proportional to SV |
|
equation for SV
|
=CO/HR
also =EDV-ESV |
|
Stroke Volume affected by
|
SV CAP.
Stroke Volume affected by Contractility, Afterload, and Preload. ↑ SV when ↑ preload, ↓ afterload, or ↑ contractility. |
|
Contractility (and SV) ↑ with:
|
1. Catecholamines (↑ activity of Ca2+pump
in sarcoplasmic reticulum) 2. ↑ intracellular calcium 3. ↓ extracellular sodium 4. Digitalis (↑ intracellular Na+, resulting in ↑ Ca2+) 5.SV ↑ in anxiety, exercise, and pregnancy. |
|
Contractility (and SV) ↓ with:
|
1. β1 blockade
2. Heart failure 3. Acidosis 4. Hypoxia/hypercapnea 5. Ca2+ channel blockers |
|
Myocardial O2 demand is ↑ by:
|
1. ↑ afterload (∝
diastolic BP) 2.↑ contractility 3. ↑ heart rate 4. ↑ heart size (↑ wall tension) |
|
Preload and
afterload aka's |
Preload = ventricular EDV.
Afterload = diastolic arterial pressure |
|
aka ventricular EDV.
|
Preload
|
|
aka diastolic arterial pressure
|
Afterload
|
|
Preload and afterload
wrt dilators |
Venous dilators (e.g., nitroglycerin) ↓ preload.
Vasodilators (e.g., hydralazine) ↓ afterload. |
|
Preload increases with (3 things)
|
Preload ↑ with exercise
(slightly), ↑ blood volume (overtransfusion), and excitement (sympathetics). Preload pumps up the heart. |
|
Starling curve
Force of contraction is proportional to |
initial length of cardiac muscle fiber (preload).
|
|
CONTRACTILE STATE OF MYOCARDIUM
+ |
-Circulating catecholamines
-Digitalis -Sympathetic stimulation |
|
CONTRACTILE STATE OF MYOCARDIUM
− |
-Pharmacologic depressants
-Loss of myocardium (MI) |
|
Ejection fraction (EF)
equation and description |
EF = SV/EDV = (EDV – ESV)/EDV
EF is an index of ventricular contractility. |
|
EF is normally
|
≥ 55%.
|
|
Resistance,
pressure, flow ∆P = |
Q × R
|
|
Resistance =
|
P/Q
or 8n(viscosity)(length)/(Pi)(R^4) |
|
Viscosity depends mostly on
|
hematocrit.
|
|
Viscosity ↑ in:
|
1. Polycythemia
2. Hyperproteinemic states (e.g., multiple myeloma) 3. Hereditary spherocytosis |
|
what vessels account for most of
total peripheral resistance and how |
Arterioles
→ regulate capillary flow. |
|
Phases–left ventricle:
Isovolumetric contraction–– |
period
between mitral valve closure and aortic valve opening; period of highest O2 consumption |
|
Phases–left ventricle:
period of highest O2 consumption |
Isovolumetric contraction––
|
|
Phases–left ventricle:
Systolic ejection– |
period between
aortic valve opening and closing |
|
Phases–left ventricle:
Isovolumetric relaxation |
––period
between aortic valve closing and mitral valve opening |
|
Phases–left ventricle:
Rapid filling–– |
period just after
mitral valve opening |
|
Phases–left ventricle:
Slow filling |
––period just before
mitral valve closure |
|
Phases–left ventricle: in order
|
1. Isovolumetric contraction
2. Systolic ejection 3. Isovolumetric relaxation 4. Rapid filling 5. Slow filling |
|
heart sound events
S1 S2 S3 S4 |
S1––mitral and tricuspid valve closure.
S2––aortic and pulmonary valve closure. S3––at end of rapid ventricular filling. S4––high atrial pressure/stiff ventricle. |
|
S3 is associated with
|
dilated CHF.
|
|
Heart sound associated with dilated CHF.
|
S3
|
|
Heart sound associated with (“atrial kick”)
|
S4 (“atrial kick”)
|
|
S4 (“atrial kick”)
is associated with |
a hypertrophic ventricle
|
|
Heart sound associated with
hypertrophic ventricle. |
S4 (“atrial kick”)
|
|
a wave=
|
a wave––atrial contraction.
|
|
c wave=
|
c wave––RV contraction (tricuspid valve
bulging into atrium). |
|
v wave=
|
v wave–– ↑ atrial pressure due to
filling against closed tricuspid valve. |
|
Normal S2 spliting
|
S2 splitting: aortic valve closes before
pulmonic; S1...A2.P2 inspiration ↑ this difference. s1...A2..P2 |
|
Wide splitting (associated with
|
Pulmonic stenosis
S1....A2(more time)P2 |
|
Fixed splitting (associated with
|
ASD
no change on inspiration |
|
Paradoxical splitting (associated with
|
Aortic stenosis
S1...P2...A2 on expire S1...P2.A2 |
|
Cardiac muscle contraction is dependent on what Ion
|
extracellular calcium,
|
|
Cardiac muscle contraction is dependent on ?????? which enters the
cells during ?????? action potential and stimulates ???????from the cardiac muscle ??????(?????????). |
extracellular calcium,
plateau of calcium release sarcoplasmic reticulum calcium-induced calcium release |
|
Cardiac myocyte physiology in contrast to skeletal muscle
WRT Plateau |
Cardiac muscle action potential has a plateau, which is due to Ca2+ influx
|
|
Cardiac myocyte physiology in contrast to skeletal muscle
WRT sponienaity |
Cardiac nodal cells spontaneously depolarize, resulting in automaticity
|
|
Cardiac myocyte physiology in contrast to skeletal muscle
WRT coupling |
Cardiac myocytes are electrically coupled to each other by gap junctions
|
|
Name 3 features of Cardiac myocyte physiology that contrast skeletal muscle
|
1. has a plateau
2. spontaneous depolarize/automaticity 3.coupled to each other by gap junctions |
|
Myocardial action potential
Which cells |
Occurs in atrial and ventricular myocytes and Purkinje fibers.
|
|
Myocardial action potential
Phase 0 |
rapid upstroke––voltage-gated Na+ channels open.
|
|
Myocardial action potential
Phase 1 |
initial repolarization with inactivation of voltage-gated Na channels. Voltage-gated K+ channels begin to open.
|
|
Myocardial action potential
Phase 2 |
plateau––Ca2+ influx through voltage-gated Ca2+ channels balances K+ efflux. Ca2+ influx triggers Ca2+ release from sarcoplasmic reticulum and myocyte contraction.
|
|
Myocardial action potential
Phase 3 |
rapid repolarization––massive K+ efflux due to opening of voltage- gated slow K+ channels and closure of voltage-gated Ca2+ channels.
|
|
Myocardial action potential
Phase 4 |
resting potential––high K+ permeability through K+ channels.
|
|
Pacemaker action potential
Which cells |
Occurs in the SA and AV nodes
|
|
Pacemaker action potential
Phase 0 |
upstroke––opening of voltage-gated Ca2+ channels. These cells lack fast
voltage-gated Na+ channels. Results in a slow conduction velocity that is used by the AV node to prolong transmission from the atria to ventricles. |
|
Pacemaker action potential
Phase 2 |
plateau is absent.
|
|
Pacemaker action potential
Phase 3 |
Inactivation of the Ca2+ channels and increase activation of the K+ channels leading to increased K+
|
|
Pacemaker action potential
Phase 4 |
Phase 4 = slow diastolic depolarization––membrane potential spontaneously depolarize as Na+ conductance ↑ (If different from INa above). Accounts for automaticity of SA and AV nodes.
|
|
Pacemaker action potential
what determines heart rate |
The slope of phase 4 in the SA node determines heart rate
|
|
Pacemaker action potential
effect of neurotransmitters on heart rate |
ACh ↓ the rate of diastolic depolarization and ↓ heart rate, while catecholamines ↑ epolariza-
tion and ↑ heart rate. |
|
Pacemaker action potential
which phase shows effect of neurotransmitters on heart rate |
Phase 4
|
|
Pacemaker action potential which phase does not exist
|
Phase 1(initial repolarization) and 2 (plateau)
|
|
ECG what is represented by the
P wave |
atrial depolarization.
|
|
ECG what is represented by the
PR segment |
conduction delay through AV node (normally < 200 msec).
|
|
ECG what is represented by the
QRS complex |
ventricular depolarization (normally < 120 msec).
|
|
ECG what is represented by the
QT interval |
mechanical contraction of the ventricles.
|
|
ECG what is represented by the
masked by QRS complex. |
Atrial repolarization
|
|
ECG what is represented by the
T wave |
ventricular repolarization.
|
|
ECG what is represented by the
ST segment |
––isoelectric, ventricles depolarized
|
|
ECG what is represented by the
U wave |
––caused by hypokalemia.
|
|
ECG normal timing of
QRS complex |
(normally < 120 msec).
|
|
ECG normal timing of
PR segment |
(normally < 200 msec).
|
|
Ventricular tachycardia characterized by shifting sinusoidal waveforms on ECG.
|
Torsades des pointes
|
|
describe Torsades des pointes
|
Ventricular tachycardia characterized by shifting sinusoidal waveforms on ECG.
|
|
Torsades des pointes complications
|
Can progress to V-fib
|
|
causes of Torsades des pointes
|
Anything that prolongs the QT interval
|
|
Anything that prolongs the QT interval can predispose to
|
Torsades des pointes
|
|
describe Wolff-Parkinson-White syndrome
|
Accessory conduction pathway from atria to ventricle (bundle of Kent), bypassing AV node.
|
|
Accessory conduction pathway from atria to ventricle (bundle of Kent), bypassing AV node.
|
Wolff-Parkinson-White syndrome
|
|
Wolff-Parkinson-White syndrome
name the accesory path |
bundle of Kent
|
|
Wolff-Parkinson-White syndrome
on ECG and why |
characteristic delta wave on ECG
due to ventricles begin to partially depolarize earlier, |
|
characteristic delta wave on ECG
|
Wolff-Parkinson-White syndrome
|
|
Wolff-Parkinson-White syndrome
complications |
May result in reentry current leading to supraventricular tachycardia.
|
|
Describe this ECG
Atrial fibrillation |
Chaotic and erratic baseline (irregularly irregular) with no discrete P waves in between
irregularly spaced QRS complexes. |
|
Describe this ECG
Atrial flutter |
A rapid succession of identical, back-to-back atrial depolarization waves. The identical appearance accounts for the “sawtooth” appearance of the flutter waves.
|
|
Describe this ECG
AV block 1st degree |
The PR interval is prolonged (> 200 msec). Asymptomatic.
|
|
Describe this ECG
AV block 2nd degree Mobitz type I |
Progressive lengthening of the PR interval until a beat is “dropped” (a P wave not followed by a QRS complex). Usually asymptomatic.
|
|
Describe this ECG
AV block 2nd degree Mobitz type II |
Dropped beats that are not preceded by a change in the length of the PR interval
|
|
Describe this ECG
AV block 3rd degree |
The atria and ventricles beat independently of each other. Both P waves and QRS
complexes are present, although the P waves bear no relation to the QRS complexes. |
|
Describe this ECG
Ventricular fibrillation |
A completely erratic rhythm with no identifiable waves.
|
|
ID the ECG
Chaotic and erratic baseline (irregularly irregular) with no discrete P waves in between irregularly spaced QRS complexes. |
Atrial fibrillation
|
|
ID the ECG
A rapid succession of identical, back-to-back atrial depolarization waves. The identical appearance accounts for the “sawtooth” appearance of the flutter waves. |
Atrial flutter
|
|
ID the ECG
The PR interval is prolonged (> 200 msec). Asymptomatic. |
AV block
1st degree |
|
ID the ECG
Progressive lengthening of the PR interval until a beat is “dropped” (a P wave not followed by a QRS complex). Usually asymptomatic. |
2nd degree
Mobitz type I (Wenckebach) |
|
ID the ECG
Dropped beats that are not preceded by a change in the length of the PR interval. These abrupt, nonconducted P waves result in a pathologic condition. |
2nd degree
Mobitz type II |
|
ID the ECG
The atria and ventricles beat independently of each other. Both P waves and QRS complexes are present, although the P waves bear no relation to the QRS complexes. |
3rd degree
(complete) |
|
ID the ECG
A completely erratic rhythm with no identifiable waves. |
Ventricular
fibrillation |
|
Wenckebach aka
|
2nd degree
Mobitz type I |
|
2nd degree Mobitz type I
aka |
Wenckebach
|
|
Tx for Atrial fibrillation
|
Anticoagulation
|
|
Tx for AV node Block 3rd degree
|
Usually treat with pacemaker.
|
|
Tx for Ventricular fibrillation
|
immediate CPR and defibrillation.
|
|
In AV node block 3rd degree (complete)
which is faster |
The atrial rate is faster than the ventricular rate. i.e P waves are faster than QRS
|
|
Control of mean arterial pressure
↑ SYMPATHETIC ACTIVITY at receptors |
β1 (↑ heart rate, ↑ contractility)— ↑ CO
α1 (venoconstriction: ↑ venous return)—↑ CO α1 (arteriolar vasoconstriction)— ↑ TPR |
|
Control of mean arterial pressure
Medullary vasomotor center senses ↓ baroreceptor firing leads to |
↑ SYMPATHETIC ACTIVITY
|
|
Control of mean arterial pressure
JGA senses ↓ MAP leads to |
↑ RENIN-ANGIOTENSIN SYSTEM
|
|
Control of mean arterial pressure
↑ RENIN-ANGIOTENSIN SYSTEM leads to |
Angiotensin II vasoconstriction)— ↑ TPR
Aldosterone (↑ blood volume)—↑ CO |
|
Baroreceptors
Aortic arch transmits via ????? to ??????(responds to ????) |
via vagus nerve
medulla only to ↑ BP |
|
Baroreceptors
Carotid sinus transmits via ????? to ???? (responds to ????) |
glossopharyngeal nerve
medulla ↓ and ↑ in BP |
|
Baroreceptors mech in Hypotension
and when is it important |
↓ arterial pressure →↓ stretch →↓ afferent baroreceptor firing →↑ efferent sympathetic firing and ↓ efferent parasympathetic stimulation →vasoconstriction, ↑ HR, ↑ contractility, ↑ BP. Important in the response to severe hemorrhage.
|
|
Carotid massage
|
↑ pressure on carotid artery →↑ stretch →↓ HR.
|
|
peripheral chemoreceptors
where and what they respond to |
Carotid and aortic bodies respond to ↓ PO2 (< 60 mmHg), ↑ PCO2,
and ↓ pH of blood. |
|
Central chemoreceptors
what they respond to |
Central: Respond to changes in pH and PCO2 of brain interstitial fluid, which in
turn are influenced by arterial CO2. Do not directly respond to PO2. |
|
central chemoreceptors
wrt a specific reaction name it and describe it |
Cushing reaction:
response to cerebral ischemia, due to ↑ intracranial pressure: hypertension (sympathetic response via peripheral vasoconstriction) and bradycardia (parasympathetic response via vaso-vagal response). |
|
Cushing reaction
|
response to cerebral ischemia, due to ↑ intracranial
pressure: hypertension (sympathetic response via peripheral vasoconstriction) and bradycardia (parasympathetic response via vaso-vagal response). |
|
response to cerebral ischemia, due to ↑ intracranial
pressure: hypertension (sympathetic response via peripheral vasoconstriction) and bradycardia (parasympathetic response via vaso-vagal response). |
Cushing reaction
|
|
Circulation through organs
Largest share of systemic cardiac output. |
Liver
|
|
Circulation through organs
Highest blood flow per gram of tissue. |
Kidney
|
|
Circulation through organs
Large arteriovenous O2 difference. ↑ O2 demand is met by ↑ coronary blood flow, not by ↑ extraction of O2. |
Heart
|
|
Circulation through organs
features of the Heart |
Large arteriovenous O2 difference. ↑ O2 demand is met by ↑ coronary blood flow, not by
↑ extraction of O2. |
|
Heart ↑ O2 demand is met by
|
↑ coronary blood flow, not by
↑ extraction of O2. |
|
PCWP
what and why |
pulmonary capillary
wedge pressure (in mmHg) is a good approximation of left atrial pressure. |
|
Swan-Ganz catheter.
|
measures pulmonary capillary
wedge pressure |
|
how to measure pulmonary capillary
wedge pressure |
Swan-Ganz catheter.
|
|
the pulmonary vasculature is unique in that hypoxia causes
|
vasoconstriction (in other organs hypoxia causes vasodilation).
|
|
the ????????? is unique in that hypoxia causes vasoconstriction
|
pulmonary vasculature
|
|
Autoregulation of blood flow
Heart |
Local metabolites: O2, adenosine, NO
|
|
Autoregulation of blood flow
Brain |
Local metabolites: CO2
(pH) |
|
Autoregulation of blood flow
Kidneys |
Myogenic and tubuloglomerular feedback
|
|
Autoregulation of blood flow
Lungs |
Hypoxia causes vasoconstriction
|
|
Autoregulation of blood flow
Skeletal muscle |
Local metabolites: lactate, adenosine, K+
|
|
Autoregulation of blood flow
Skin |
Sympathetic stimulation most important
mechanism––temperature control |
|
Name the strucure where blod flow is controlled by
Local metabolites: O2, adenosine, NO |
Heart
|
|
Name the strucure where blod flow is controlled by
Local metabolites: CO2 (pH) |
Brain
|
|
Name the strucure where blod flow is controlled by
Myogenic and tubuloglomerular feedback |
Kidneys
|
|
Name the strucure where blod flow is controlled by
Hypoxia causes vasoconstriction |
Lungs
|
|
Name the strucure where blod flow is controlled by
Local metabolites: lactate, adenosine, K+ |
Skeletal muscle
|
|
Name the strucure where blod flow is controlled by
Sympathetic stimulation most important mechanism––temperature control |
Skin
|
|
4 Starling forces determine fluid movement through capillary membranes:
|
1. Pc = capillary pressure––moves fluid out
2. Pi= interstitial fluid pressure––moves fluid in 3. πc = plasma colloid osmotic pressure––moves fluid in 4. πi = interstitial fluid colloid osmotic Pressure –moves fluid out |
|
Thus, net filtration pressure =
|
P = [(Pc − Pi ) − (πc −πi )].
|
|
Capillary fluid exchange
Kf= |
filtration constant (capillary permeability).
|
|
Capillary fluid exchange
Net fluid flow = |
(Pnet)X(Kf)
|
|
4 causes of Edema with mechs
|
1. (↑ Pc; heart failure)
2. ↓ plasma proteins (↓πc; nephrotic syndrome, liver failure) 3. ↑ capillary permeability (↑ Kf; toxins, infections, burns) 4. ↑ interstitial fluid colloid osmotic pressure (↑πi lymphatic blockage) |
|
early cyanosis
|
Right-to-left shunts “blue babies”
The 3 T’s: Tetralogy Transposition Truncus |
|
late cyanosis
|
Left-to-right shunts “blue kids”
1. VSD 2. ASD 3. PDA |
|
Freq of Left-to-right shunts
|
VSD > ASD > PDA.
|
|
Left-to-right shunts
complications |
↑ pulmonary resistance due
to arteriolar thickening. → progressive pulmonary hypertension; leading to R → L shunt (Eisenmenger’s). |
|
Eisenmenger’s
syndrome |
Uncorrected VSD, ASD, or PDA leads to progressive
pulmonary hypertension. As pulmonary resistance ↑, the shunt reverses from L → R to R → L, which causes late cyanosis |
|
Tetralogy of Fallot
why do kids squat |
to ↑ systemic vascular resistance and thereby reduce the R-L shunting
|
|
Tetralogy of Fallot
4 characteristics |
1. Pulmonary stenosis
2. RVH 3. Overriding aorta (overrides the VSD) 4. VSD |
|
Eisenmenger’s syndrome
2 "other" complications |
(clubbing and polycythemia).
|
|
Tetralogy of Fallot most important determinant for prognosis
|
Pulmonary stenosis
|
|
Tetralogy of Fallot is caused by
|
anterosuperior displacement of the infundibular septum.
|
|
Tetralogy of Fallot CXR
|
boot-shaped heart due to RVH.
|
|
Transposition of great vessels
how can they live |
VSD,
PDA, patent foramen ovale |
|
Transposition of great vessels is due to
|
failure of the aorticopulmonary septum to spiral.
|
|
Transposition of great vessels
course |
Without surgical correction, most infants die within the first few months of life.
|
|
Coarctation of aorta
Infantile type |
Infantile type: aortic stenosis proximal to insertion
of ductus arteriosus (preductal). |
|
Coarctation of aorta
Adult type |
Adult type: stenosis is distal to ductus arteriosus
(postductal). Associated with notching of the ribs, hypertension in upper extremities, weak pulses in lower extremities. |
|
Associated with notching of the ribs hypertension in upper extremities, weak pulses in
lower extremities. |
Coarctation of aorta
Adult type/postductal |
|
Coarctation of aorta
who? |
Male-to-female ratio 3:1.
|
|
Coarctation of aorta
Dx |
weak femoral pulses on
physical exam. |
|
Coarctation of aorta
mnemonic |
INfantile: IN close to
the heart. ADult: Distal to Ductus. |
|
??????? is used to close a
PDA. ??????is used to keep a PDA open, which may be |
Indomethacin
PGE |
|
Patent ductus arteriosus
what keeps it open in the body |
PGE synthesis and low O2 tension.
|
|
continuous, “machine-like” murmur
|
PDA
|
|
Congenital cardiac defect associations
22q11 syndromes |
Truncus arteriosus, tetralogy
of Fallot |
|
Congenital cardiac defect associations
Down syndrome |
ASD, VSD
|
|
Congenital cardiac defect associations
Congenital rubella |
Septal defects, PDA
|
|
Congenital cardiac defect associations
Turner’s syndrome |
Coarctation of aorta
|
|
Congenital cardiac defect associations
Marfan’s syndrome |
Aortic insufficiency
|
|
Congenital cardiac defect associations
Offspring of diabetic mother |
Transposition of great vessels
|
|
Congenital cardiac defect associations
Truncus arteriosus, tetralogy of Fallot |
22q11 syndromes
|
|
Congenital cardiac defect associations
ASD, VSD |
Down syndrome
|
|
Congenital cardiac defect associations
Septal defects, PDA |
Congenital rubella
|
|
Congenital cardiac defect associations
Aortic insufficiency |
Marfan’s syndrome
|
|
Congenital cardiac defect associations
Coarctation of aorta |
Turner’s syndrome
|
|
Congenital cardiac defect associations
Transposition of great vessels |
Offspring of diabetic mother
|
|
Hypertension Defined as
|
BP ≥ 140/90.
|
|
Hypertension
Risk factors |
↑ age, obesity, diabetes, smoking, genetics, black > white > Asian.
|
|
Hypertension
types |
90% of hypertension is 1° (essential) and related to ↑ CO or ↑ TPR; remaining 10%
mostly 2° to renal disease. Malignant hypertension is severe and rapidly progressing |
|
Hypertension
Predisposes to |
Atherosclerosis,
stroke, CHF, renal failure, retinopathy, aortic dissection. |
|
Atheromata
|
Plaques in blood vessel walls.
|
|
Plaques in blood vessel walls.
|
Atheromata
|
|
Xanthoma
|
Plaques or nodules composed of lipid-laden histiocytes in the skin, especially the
eyelids. |
|
Plaques or nodules composed of lipid-laden histiocytes in the skin, especially the
eyelids. |
Xanthoma
|
|
Tendinous xanthoma
|
Lipid deposit in tendon, especially Achilles.
|
|
Lipid deposit in tendon, especially Achilles.
|
Tendinous xanthoma
|
|
Corneal arcus
|
Lipid deposit in cornea, nonspecific (arcus senilis).
|
|
Lipid deposit in cornea, nonspecific (arcus senilis).
|
Corneal arcus
|
|
Mönckeberg
|
Calcification of the arteries, especially radial or ulnar. Usually benign; "pipestem
arteries." |
|
Calcification of the arteries, especially radial or ulnar. Usually benign; "pipestem
arteries." |
Mönckeberg
|
|
Arteriolosclerosis
|
Hyaline thickening of small arteries in essential hypertension. Hyperplastic “onion
skinning” in malignant hypertension. |
|
Hyaline thickening of small arteries in essential hypertension. Hyperplastic “onion
skinning” in malignant hypertension. |
Arteriolosclerosis
|
|
Atherosclerosis
|
Fibrous plaques and atheromas form in intima of arteries.
|
|
Fibrous plaques and atheromas form in intima of arteries.
|
Atherosclerosis
|
|
Atherosclerosis
which arteries |
Disease of elastic arteries and large and medium-sized muscular arteries
|
|
Atherosclerosis
Risk factors |
Smoking,
hypertension, diabetes mellitus, hyperlipidemia, family history. |
|
Atherosclerosis
Progression |
Fatty streaks → proliferative plaque → complex atheromas.
|
|
Atherosclerosis
Complications |
Aneurysms, ischemia, infarcts, peripheral vascular disease, thrombus, emboli.
|
|
Atherosclerosis
Location |
Abdominal aorta > coronary artery > popliteal artery > carotid artery.
|
|
Atherosclerosis
Symptoms |
Angina, claudication, but can be asymptomatic.
|
|
Ischemic heart disease
Possible manifestations: |
1. Angina
2. Myocardial infarction 3. Sudden cardiac death 4. Chronic ischemic heart disease |
|
when does Angina occur
|
(CAD narrowing > 75%):
|
|
Angina
types and features |
a. Stable –mostly 2° to atherosclerosis (retrosternal chest pain with exertion)
b. Prinzmetal’s variant –occurs at rest 2° to coronary artery spasm c.Unstable/crescendo –thrombosis but no necrosis (worsening chest pain) |
|
which Angina
occurs at rest 2° to coronary artery spasm |
Prinzmetal’s varian
|
|
which Angina
mostly 2° to atherosclerosis |
Stable
|
|
which Angina
thrombosis but no necrosis |
Unstable/crescendo
|
|
most often cause of MI
|
most often acute thrombosis from coronary artery atherosclerosis.
|
|
Sudden cardiac death most common cause
|
lethal arrhythmia
|
|
What is Sudden cardiac death
|
death from cardiac causes within 1 hour of onset of
symptoms |
|
what is Chronic ischemic heart disease
|
progressive onset of CHF over many years due to chronic ischemic myocardial damage
|
|
Red (hemorrhagic) infarcts occur in
|
loose tissues with collaterals, such as lungs, liver, intestine, or following reperfusion.
|
|
Pale infarcts occur in
|
solid tissues with single blood
supply, such as brain, heart, kidney, and spleen. |
|
Coronary artery occlusion frequency
|
LAD > RCA > circumflex.
|
|
MI symptoms
|
Diaphoresis,
nausea and vomiting, severe retrosternal pain, pain in left arm and/or jaw, shortness of breath, fatigue, adrenergic symptoms |
|
MI markers
Cardiac troponin I rises |
after 4 hours
peaks at 24 and is elevated for 7–10 days; |
|
MI markers
more specific than other protein markers. |
Cardiac troponin I
|
|
MI markers
rises after 4 hours and is elevate for 7–10 days; |
Cardiac troponin I
|
|
MI markers
CK-MB rises |
4-8 hours
peaks at 24 gone in 2-3 days |
|
MI markers
predominantly found in myocardium but can also be released from skeletal muscle |
CK-MB
|
|
MI markers
is nonspecific and can be found in cardiac, liver, and skeletal muscle cells |
AST
|
|
MI markers
AST rises |
by 18 hours
peaks at 1.5 days |
|
MI markers
LDH rises |
in 10 hours
peaks at 2-3 days gone in 7 |
|
Diagnosis of MI In the first 6 hours, ?????? is the gold standard.
|
ECG i
|
|
Diagnosis of MI wrt ECG
|
changes can include:
ST elevation (transmural infarct), ST depression (subendocardial infarct), pathological Q waves (transmural infarct). |
|
MI complications
Cardiac arrhythmia |
important cause of death before reaching hospital; common in
first few days |
|
MI complications
Aneurysm formation |
↓ CO, risk of arrhythmia, embolus from mural thrombus
|
|
MI complications
Fibrinous pericarditis |
friction rub (3–5 days post-MI)
|
|
Dressler’s syndrome
|
autoimmune phenomenon resulting in fibrinous pericarditis
(several weeks post-MI) |
|
autoimmune phenomenon resulting in fibrinous pericarditis
(several weeks post-MI) |
Dressler’s syndrome
|
|
friction rub (3–5 days post-MI)
|
Fibrinous pericarditi
|
|
4–10 days post–MI; can lead to cardiac tamponade.
|
Rupture
|
|
Most common cardiomyopathy (90% of cases).
|
Dilated (congestive)
cardiomyopathy |
|
Dilated cardiomyopathy
causes |
chronic Alcohol abuse,
Beriberi, Coxsackie B virus myocarditis, chronic Cocaine use, Chagas’ disease, Doxorubicin toxicity, peripartum cardiomyopathy. |
|
Dilated cardiomyopathy CXR
|
Heart dilates and looks like a balloon on
chest x-ray. |
|
Dilated cardiomyopathy what type of dysfunction
|
Systolic dysfunction ensues.
|
|
Hypertrophic cardiomyopathy what type of dysfunction
|
Diastolic dysfunction ensues.
|
|
Cause of sudden death in young athletes.
|
Hypertrophic cardiomyopathy
|
|
Hypertrophy often asymmetric and involving the intraventricular septum. Normal heart size.
|
Hypertrophic cardiomyopathy
|
|
describe Hypertrophic cardiomyopathy
|
Hypertrophy often asymmetric and involving the intraventricular septum. Normal heart size.
|
|
Hypertrophic cardiomyopathy CXR
|
Normal heart size.
|
|
Hypertrophic cardiomyopathy causes
|
50% of cases are familial, autosomal dominant.
|
|
Hypertrophic cardiomyopathy
Dx |
Findings: loud S4, apical impulses, systolic
murmur. |
|
Hypertrophic cardiomyopathy
Tx |
Treat with β-blocker. and/or Surgical septal myectomy
|
|
causes of Restrictive/obliterative
cardiomyopathy |
sarcoidosis,
amyloidosis, postradiation fibrosis, endocardial fibroelastosis, endomyocardial fibrosis (Löffler’s), hemochromatosis (dilated cardiomyopathy can also occur). |
|
Heart sounds
Holosystolic high-pitched “blowing murmur.” Loudest at apex. |
Mitral regurgitation
|
|
Heart sounds
Mitral regurgitation |
Holosystolic high-pitched “blowing murmur.” Loudest at apex.
|
|
Heart sounds
Crescendo-decrescendo systolic ejection murmur |
Aortic stenosis
|
|
Heart sounds
LV >> aortic pressure during systole |
Aortic stenosis
|
|
Heart sounds
“Pulsus parvus et tardus” |
pulses weak compared
to heart sounds. aortic stenosis |
|
Heart sounds
Holosystolic murmur. |
VSD
|
|
Heart sounds
Late systolic murmur with midsystolic click. |
Mitral prolapse
|
|
Heart sounds
Most frequent valvular lesion. |
Mitral prolapse
|
|
Heart sounds
Immediate high-pitched “blowing” diastolic murmur. Wide pulse pressure. |
Aortic regurgitation
|
|
Heart sounds
Follows opening snap. Delayed rumbling late diastolic murmur. |
Mitral stenosis
|
|
Heart sounds
LA >> LV pressure during diastole. |
Mitral stenosis
|
|
Heart sounds
Mitral vs Tricuspid stenosis |
Tricuspid stenosis differs because
it gets louder with inspiration. |
|
Heart sounds
PDA |
Continuous machine-like murmur. Loudest at time of S2.
|
|
Heart sounds
Continuous machine-like murmur. Loudest at time of S2. |
PDA
|
|
CHF what is the cause of
Dyspnea on exertion |
Failure of LV output to ↑
during exercise. |
|
CHF what is the cause of
Cardiac dilation |
Greater ventricular end-diastolic
volume. |
|
CHF what is the cause of
Pulmonary edema, paroxysmal nocturnal dyspnea |
LV failure →↑ pulmonary
venous pressure → pulmonary venous distention and transudation of fluid. |
|
CHF what is the cause of
Orthopnea |
↑ venous return in supine
position exacerbates pulmonary vascular congestion. |
|
CHF what is the cause of
Hepatomegaly (nutmeg liver) |
↑ central venous pressure
→↑ resistance to portal flow. Rarely, leads to “cardiac cirrhosis.” |
|
CHF what is the cause of
Ankle, sacral edema |
RV failure →↑ venous pressure
→ fluid transudation. |
|
CHF what is the cause of
Jugular venous distention |
R heart failure →↑ venous pressure.
|
|
hemosiderin-laden
macrophages (“heart failure” cells). |
(“heart failure”
cells). |
|
“heart failure” cells
|
hemosiderin-laden
macrophages |
|
Embolus types
|
An embolus moves like a FAT
BAT. Fat, Air, Thrombus, Bacteria, Amniotic fluid, Tumor. |
|
Fat emboli are associated with
|
acute long bone fractures and liposuction.
|
|
Amniotic fluid emboli can lead to
|
DIC,
|
|
Pulmonary embolus clinical findings
|
chest pain, tachypnea,
dyspnea. |
|
Virchow’s triad:
|
1. Stasis
2. Hypercoagulability 3. Endothelial damage |
|
Cardiac tamponade
|
Compression of heart by fluid (i.e., blood) in pericardium, leading to ↓ CO.
|
|
Compression of heart by fluid (i.e., blood) in pericardium, leading to ↓ CO.
|
Cardiac tamponade
|
|
Cardiac tamponade and pressure changes
|
Equilibration of diastolic pressures in all 4 chambers of the heart with intrapericardial pressure
|
|
Cardiac tamponade
clinical findings |
hypotension,
↑ venous pressure (JVD), distant heart sounds, ↑ HR, pulsus paradoxus; |
|
pulsus paradoxus
|
is an exaggeration of the normal variation in the pulse during the inspiratory phase of respiration, in which the pulse becomes weaker as one inhales and stronger as one exhales
|
|
Cardiac tamponade
ECG findings |
ECG shows electrical alternans (beat-to-beat alterations of QRS
complex height). |
|
what are ECG electrical alternans and what do they mean
|
beat-to-beat alterations of QRS
complex height Cardiac tamponade |
|
Osler’s nodes
|
Osler's nodes are painful, red, raised lesions on the finger pulps, indicative of the heart disease subacute Infective endocarditis. They are caused by immune complex deposition.
|
|
Osler's nodes are painful, red, raised lesions on the finger pulps, indicative of the heart disease subacute Infective endocarditis. They are caused by immune complex deposition.
|
Osler’s nodes
|
|
Bacterial endocarditis
clinical findings |
Bacteria FROM JANE
Fever Roth’s spots Osler’s nodes Murmur Janeway lesions Anemia Nail-bed hemorrhage Emboli |
|
Roth's spots
|
retinal hemorrhages with white or pale centers composed of coagulated fibrin. immune complex mediated vasculitis often resulting from bacterial endocarditis
|
|
retinal hemorrhages with white or pale centers composed of coagulated fibrin immune complex mediated vasculitis often resulting from bacterial endocarditis
|
Roth's spots
|
|
Janeway lesions
what who mech |
non-tender, small erythematous or haemorrhagic macules or nodules in the palms or soles,
are pathognomonic of infective endocarditis. The pathology is due to a type III hypersensitivity reaction. |
|
non-tender, small erythematous or haemorrhagic macules or nodules in the palms or soles, which are pathognomonic of infective endocarditis. The pathology is due to a type III hypersensitivity reaction.
|
Janeway lesions
|
|
Bacterial endocarditis
most common valve |
Mitral
|
|
Bacterial endocarditis
most common valve in IVDA |
Tricuspid
|
|
Bacterial endocarditis
acute |
1. Acute––S. aureus (high virulence). Large
vegetations on previously normal valves. Rapid onset. |
|
Bacterial endocarditis
subacute |
2. Subacute––viridans streptococcus (low virulence). Smaller vegetations on congenitally abnormal or diseased valves.
|
|
Bacterial endocarditis
Sequela of dental procedures |
subacute - viridans streptococcus
|
|
Bacterial endocarditis
complications |
chordae rupture,
glomerulonephritis, suppurative pericarditis, emboli. |
|
Endocarditis may also be nonbacterial 2° to
|
metastasis or renal failure (marantic/thrombotic endocarditis).
|
|
Libman-Sacks
endocarditis |
Vegetations develop on both sides of valve (→ mitral valve stenosis) but do not embolize. Seen in lupus.
|
|
Vegetations develop on both sides of valve (→ mitral valve stenosis) but do not embolize. Seen in lupus.
|
Libman-Sacks
endocarditis |
|
endocarditis seen in Lupus
|
Libman-Sacks
-- SLE causes LSE. |
|
Rheumatic fever is a consequence of
|
pharyngeal infection with group A β-hemolytic strep
|
|
Rheumatic fever
early cause of death |
Early deaths due to myocarditis.
|
|
rheumatic heart disease
affects which heart valves |
––mitral > aortic >>
tricuspid (high-pressure valves affected most). |
|
Rheumatic heart disease
Micro |
Associated with Aschoff bodies (granuloma with giant cells),
Anitschkow's cells (activated histiocytes), |
|
What are Aschoff bodies
|
granuloma with giant cells
|
|
What are Anitschkow's cells
|
activated histiocytes
|
|
Jones criteria
|
diagnosis of rheumatic fever
# Joints (Migratory polyarthritis): # O [imagine heart-shaped O] (carditis): # Erythema marginatum # Sydenham's chorea (St. Vitus' dance) |
|
diagnosis of rheumatic fever
|
Jones criteria
# Joints (Migratory polyarthritis): # O [imagine heart-shaped O] (carditis): # Erythema marginatum # Sydenham's chorea (St. Vitus' dance) |
|
diagnosis of rheumatic fever
lab test |
ESR ↑
elevated ASO titers. |
|
diagnosis of rheumatic fever
Jones criteria J |
Joints (Migratory polyarthritis): a temporary migrating inflammation of the large joints, usually starting in the legs and migrating upwards.
|
|
diagnosis of rheumatic fever
Jones criteria O |
O [imagine heart-shaped O] (carditis): inflammation of the heart muscle which can manifest as congestive heart failure
|
|
diagnosis of rheumatic fever
Jones criteria N |
Nodules (subcutaneous nodules - a form of Aschoff bodies): painless, firm collections of collagen fibers on the back of the wrist, the outside elbow, and the front of the knees.
|
|
diagnosis of rheumatic fever
Jones criteria E |
Erythema marginatum: a long lasting rash that begins on the trunk or arms as macules and spreads outward to form a snakelike ring while clearing in the middle. This rash never starts on the face and is made worse with heat.
|
|
diagnosis of rheumatic fever
Jones criteria S |
Sydenham's chorea (St. Vitus' dance): a characteristic series of rapid movements without purpose of the face and arms.
|
|
cause of Serous Pericarditis
|
SLE, rheumatoid arthritis, infection, uremia.
|
|
cause of Fibrinous Pericarditis
|
Uremia, MI (Dressler's syndrome), rheumatic fever.
|
|
cause of Hemorrhagic Pericarditis
|
TB, malignancy (e.g., melanoma).
|
|
Pericarditis
Clinical findings |
Findings: pericardial pain, friction rub, pulsus paradoxus, distant heart sounds.
|
|
Pericarditis
ECG findings |
ECG changes (diffuse ST elevations in all leads),
|
|
Pericarditis
course |
Can resolve without scarring or lead to chronic adhesive or chronic constrictive
pericarditis. |
|
Syphilitic heart
disease |
3° syphilis disrupts the vasa vasora of the aorta
with consequent dilation of the aorta and valve ring Often affects the aortic root and calcification of ascending arch of the aorta. |
|
disrupts the vasa vasora of the aorta with consequent dilation of the aorta and valve ring Often affects the aortic root and calcification of ascending arch of the aorta.
|
3° syphilis
|
|
Syphilitic heart disease
can result in |
aneurysm of the ascending aorta or aortic arch and aortic valve
incompetence. |
|
Syphilitic heart disease
wrt visualization |
May see calcification of the aortic root and ascending
aortic arch. |
|
Syphilitic heart disease
which stage of syphilis |
3° syphilis
|
|
most common 1° cardiac tumor in adults
|
Myxomas
|
|
Myxomas
where are they and imps |
90% occur in the atria
(mostly LA). Myxomas are usually described as a “ball-valve” obstruction in the LA. |
|
“ball-valve” obstruction in the LA.
|
Myxomas
|
|
most frequent 1° cardiac tumor in children
|
Rhabdomyomas
|
|
Rhabdomyoma association
|
associated with
tuberous sclerosis |
|
heart tumor associated with
tuberous sclerosis |
Rhabdomyomas
|
|
most common heart tumor
|
Metastases
|
|
Kussmaul's sign
|
observation of a jugular venous pressure (JVP, the filling of the jugular vein) that rises with inspiration
|
|
Cardiac tumors
wrt special sign |
Kussmaul's sign
|
|
observation of a jugular venous pressure (JVP, the filling of the jugular vein) that rises with inspiration
|
Kussmaul's sign
|
|
Adverse effects of
Antihypertensive drugs Hydrochlorothiazide |
Hypokalemia,
hyperlipidemia, hyperuricemia, lassitude, hypercalcemia, hyperglycemia |
|
Adverse effects of
Antihypertensive drugs Loop diuretics |
Potassium wasting,
metabolic alkalosis, hypotension, ototoxicity |
|
Adverse effects of
Antihypertensive drugs Clonidine |
Dry mouth,
sedation, severe rebound hypertension |
|
Adverse effects of
Antihypertensive drugs Methyldopa |
Sedation,
positive Coombs’ test |
|
Adverse effects of
Antihypertensive drugs Hexamethonium |
Severe orthostatic hypotension, blurred vision,
constipation, sexual dysfunction |
|
Adverse effects of
Antihypertensive drugs Reserpine |
Sedation,
depression, nasal stuffiness, diarrhea |
|
Adverse effects of
Antihypertensive drugs Guanethidine |
Orthostatic and exercise hypotension,
sexual dysfunction, diarrhea |
|
Adverse effects of
Antihypertensive drugs Prazosin |
1st-dose orthostatic hypotension, dizziness,
headache |
|
Adverse effects of
Antihypertensive drugs β-blockers |
Impotence,
asthma, cardiovascular effects (bradycardia, CHF, AV block), CNS effects (sedation, sleep alterations) |
|
Adverse effects of
Antihypertensive drugs Hydralazine |
Nausea, headache,
lupus-like syndrome, reflex tachycardia, angina, salt retention |
|
Adverse effects of
Antihypertensive drugs Minoxidil |
Hypertrichosis,
pericardial effusion, reflex tachycardia, angina, salt retention |
|
Adverse effects of
Antihypertensive drugs Nifedipine, |
Dizziness,
flushing, nausea |
|
Adverse effects of
Antihypertensive drugs verapamil |
constipation
Dizziness, flushing, nausea |
|
Adverse effects of
Antihypertensive drugs Nitroprusside |
Cyanide toxicity (releases CN)
|
|
Adverse effects of
Antihypertensive drugs ACE inhibitors |
Hyperkalemia,
Cough, Angioedema, Proteinuria, Taste changes, hypOtension, Pregnancy problems (fetal renal damage), Rash, Increased renin, Lower angiotensin II |
|
Adverse effects of
Antihypertensive drugs Angiotensin II receptor Inhibitors |
Fetal renal toxicity, hyperkalemia
|
|
Which Antihypertensive drug has this adverse effect
Hypokalemia |
Hydrochlorothiazide
and Loop diuretics |
|
Which Antihypertensive drug has this adverse effect
ototoxicity |
Loop diuretics
|
|
Which Antihypertensive drug has this adverse effect
Dry mouth, sedation, severe rebound hypertension |
Clonidine
|
|
Which Antihypertensive drug has this adverse effect
positive Coombs’ test |
Methyldopa
|
|
Which Antihypertensive drug has this adverse effect
Severe orthostatic hypotension, blurred vision |
Hexamethonium
|
|
Which Antihypertensive drug has this adverse effect
Sedation, depression, nasal stuffiness |
Reserpine
|
|
Which Antihypertensive drug has this adverse effect
lupus-like syndrome |
Hydralazine
|
|
Which Antihypertensive drug has this adverse effect
Cyanide toxicity (releases CN) |
Nitroprusside
|
|
Which Antihypertensive drug has this adverse effect
pericardial effusion |
Minoxidil
|
|
Which Antihypertensive drug has this adverse effect
Pregnancy problems (fetal renal damage) |
ACE inhibitors
and ARB's |
|
Which Antihypertensive drug has this adverse effect
Hyperkalemia, Cough |
ACE inhibitors
|
|
Which Antihypertensive drug has this adverse effect
Increased renin, Lower angiotensin II |
ACE inhibitors
|
|
Which Antihypertensive drug has this adverse effect
hyperkalemia |
ACE inhibitors
and ARB's |
|
Which Antihypertensive drug has this adverse effect
Taste changes |
ACE inhibitors
|
|
Which antihypertensive agent
Use with β-blockers to prevent reflex tachycardia, diuretic to block salt retention. |
Hydralazine
Minoxidil |
|
special considerations for using
Hydralazine or Minoxidil |
Use with β-blockers to prevent reflex tachycardia, diuretic to block salt retention.
|
|
Antihypertensive drugs
name the Sympathoplegics |
Clonidine
Methyldopa Hexamethonium Reserpine Guanethidine Prazosin β-blockers |
|
Antihypertensive drugs
name the Vasodilators |
Hydralazine
Minoxidil Nifedipine, verapamil Nitroprusside |
|
Antihypertensive drugs
name the ACE inhibitors |
-pril's
|
|
Antihypertensive drugs
name the Angiotensin II receptor inhibitors |
-sartan's
|
|
Hydralazine
Mechanism |
↑ cGMP →smooth muscle relaxation. Vasodilates arterioles > veins; afterload reduction.
|
|
Hydralazine
Clinical use |
Severe hypertension, CHF. First-line for HTN in pregnancy, with methyldopa.
|
|
Hydralazine
Toxicity |
Compensatory tachycardia, fluid/salt retention. Lupus-like syndrome.
|
|
Calcium channel blockers
names |
Nifedipine, verapamil, diltiazem.
|
|
Calcium channel blockers
Mechanism |
Block voltage-dependent L-type calcium channels of cardiac and smooth muscle and thereby reduce muscle contractility.
|
|
Calcium channel blockers
Clinical use |
Hypertension, angina, arrhythmias (not nifedipine), Prinzmetal's angina, Raynaud's.
|
|
Calcium channel blockers
Toxicity |
Cardiac depression, peripheral edema, flushing, dizziness, and constipation.
|
|
Calcium channel blockers
which one not to use for arrhythmias |
nifedipine
|
|
Calcium channel blockers
relative effects on Vascular smooth muscle vs Heart |
Vascular smooth muscle nifedipine > diltiazem > verapamil.
Heart– verapamil > diltiazem > nifedipine. |
|
Nitroglycerin, isosorbide dinitrate
Mechanism |
Vasodilate by releasing nitric oxide in smooth muscle, causing ↑ in cGMP and smooth
muscle relaxation. Dilate veins >> arteries. ↓ preload. |
|
Nitroglycerin, isosorbide dinitrate
Clinical use |
Angina, pulmonary edema. Also used as an aphrodisiac and erection enhancer.
|
|
Nitroglycerin, isosorbide dinitrate
Toxicity |
Tachycardia,
hypotension, flushing, headache, “Monday disease” in industrial exposure/ development of tolerance |
|
“Monday disease”
|
in industrial exposure,
development of tolerance for the vasodilating action during the work week and loss of tolerance over the weekend, resulting in tachycardia, dizziness, and headache. |
|
Antianginal therapy
goals |
reduction of myocardial O2 consumption by decreasing 1 or more of the
determinants: end diastolic volume, blood pressure, heart rate, contractility, ejection time. |
|
Calcium channel blocker
wrt Antiangianl effects |
Nifedipine is similar to Nitrates in effect;
verapamil is similar to β-blockers in effect. |
|
Cardiac glycosides
names |
Digoxin, ...
|
|
Digoxin
pharmacokinetics |
75% bioavailability,
20–40% protein bound, t1/2 = 40 hours, urinary excretion. |
|
Cardiac glycosides
Mechanism |
Direct inhibition of Na+/K+ ATPase leads to indirect inhibition of Na+/Ca2+ exchanger/
antiport. ↑ intracellular [Ca2+] → + ionotropy. |
|
Cardiac glycosides
Clinical use and reasons |
CHF (↑ contractility);
atrial fibrillation (↓ conduction at AV node and depression of SA node). |
|
Cardiac glycosides
Toxicity |
May cause ↑ PR, ↓ QT, scooping of ST segment, T-wave inversion of ECG. Also
↑ parasympathetic activity: nausea, vomiting, diarrhea, blurry yellow vision , Arrhythmias |
|
Cardiac glycosides
Antidote |
Slowly normalize K+,
lidocaine, cardiac pacer, anti-dig Fab fragments. |
|
Digoxin
factors that affect its toxicities |
Toxicity of digoxin are ↑ by: renal failure (↓ excretion)
hypokalemia (potentiates drug’s effects), quinidine (↓ digoxin clearance by displacing digoxin from tissue binding sites). |
|
Antiarrhythmics
Class I mech and features |
Slow or block (↓) conduction (especially in depolarized cells). ↓ slope of phase 4 depolarization and ↑ threshold for firing in abnormal pacemaker cells.
|
|
Antiarrhythmics
Class I selectivity |
Are state dependent (selectively depress tissue that is frequently depolarized,
e.g., fast tachycardia). |
|
Antiarrhythmics
Class IA names |
“Queen Amy Proclaims
Dis o' pyramid.” Quinidine, Amiodarone, Procainamide, Disopyramide. |
|
Antiarrhythmics
Class IA what they affect |
↑ AP duration, ↑ effective refractory period (ERP),
↑ QT interval. |
|
Antiarrhythmics
Class IA used for |
Affect both atrial and ventricular arrhythmias especially reentrant and ectopic supraventricular and ventricular tachycardia.
|
|
Antiarrhythmics
Class IA toxicities Quinidine |
cinchonism––headache,
tinnitus; thrombocytopenia; torsades de pointes due to ↑ QT interval) |
|
Antiarrhythmics
Class IA toxicities Procainamide |
reversible SLE-like
syndrome |
|
Cinchonism
|
or quinism is a pathological condition in humans caused by an overdose of quinine or its natural source, cinchona bark
|
|
a pathological condition in humans caused by an overdose of quinine or its natural source, cinchona bark
|
cinchonism or quinism
|
|
Which antiarrhythmic toxicity has
cinchonism––headache, tinnitus; thrombocytopenia; |
Quinidine
|
|
Which antiarrhythmic toxicity has
reversible SLE-like syndrome |
Procainamide
|
|
Antiarrhythmics
Class IB names |
Lidy's Mexican Tacos
Lidocaine, mexiletine, tocainide |
|
Antiarrhythmics
Class IB effect |
↓ AP duration.
Affect ischemic or depolarized Purkinje and ventricular tissue. |
|
Antiarrhythmics
Class IB uses |
Useful in acute ventricular
arrhythmias (especially post-MI) and in digitalis induced arrhythmias. |
|
Antiarrhythmics
Class IB Toxicity |
local anesthetic.
CNS stimulation/depression, cardiovascular depression. |
|
Antiarrhythmics
Class IC Toxicity |
proarrhythmic, especially post-MI
(contraindicated). Significantly prolongs refractory period in AV node. |
|
Antiarrhythmics
Class IC names |
Flecainide, encainide, propafenone.
|
|
Antiarrhythmics
Class IC effect |
No effect on
AP duration. |
|
Antiarrhythmics
Class IC uses |
Useful in V-tachs that progress to VF and in intractable SVT. Usually used only as last resort in refractory tachyarrhythmias.
|
|
Antiarrhythmics
Class II names |
β-blockers
|
|
Antiarrhythmics
Class II effects |
↓ cAMP, ↓ Ca2+ currents. Suppress abnormal pacemakers by ↓ slope of phase 4.
AV node particularly sensitive––↑ PR interval. |
|
Antiarrhythmics
Class II Which is very short acting |
Esmolol
|
|
Antiarrhythmics
Class II toxicity in general |
Impotence, exacerbation of asthma, cardiovascular effects (bradycardia,
AV block, CHF), CNS effects (sedation, sleep alterations). May mask the signs of hypoglycemia. |
|
Antiarrhythmics
Class II toxicity of metoprolol |
can cause dyslipidemia.
|
|
Antiarrhythmics
Class II can cause dyslipidemia. |
metoprolol
|
|
Antiarrhythmics
Class III name them |
K+ channel blockers
Sotalol, ibutilide, bretylium, amiodarone. |
|
Antiarrhythmics
Class III mech |
↑ AP duration, ↑ ERP. Used when other
antiarrhythmics fail. ↑ QT interval. |
|
Antiarrhythmics
Class III Toxicity Sotalol |
Sotalol––torsades de pointes, excessive β block;
|
|
Sotalol
which class of Antiarrhythmics |
Class III
|
|
Antiarrhythmics
Class III Toxicity torsades de pointes |
Sotalol
and ibutilide |
|
Antiarrhythmics
Class III Toxicity ibutilide |
torsades;
|
|
Antiarrhythmics
Class III Toxicity bretylium |
hypotension
and new arrhythmias |
|
Antiarrhythmics
Class III Toxicity hypotension and new arrhythmias |
bretylium
|
|
Antiarrhythmics
Class III Toxicity pulmonary fibrosis |
amiodarone
|
|
Antiarrhythmics
Class III Toxicity amiodarone |
pulmonary fibrosis,
corneal deposits, hepatotoxicity, skin deposits resulting in photodermatitis, neurologic effects, constipation, cardiovascular effects (bradycardia, heart block, CHF), hypothyroidism/ hyperthyroidism. |
|
Antiarrhythmics
Class III Toxicity hypothyroidism/ hyperthyroidism. |
amiodarone
|
|
Antiarrhythmics
Class III Toxicity corneal deposits |
amiodarone
|
|
Antiarrhythmics
Class III Toxicity skin deposits |
amiodarone
|
|
What to check when using amiodarone
|
P(pulmonary)FTs,
LFTs, and TFTs when |
|
Amiodarone is safe to use in
????? syndrome. |
Wolff-Parkinson-White
|
|
??????is safe to use in
Wolff-Parkinson-White syndrome. |
Amiodarone
|
|
Antiarrhythmics
Class IV names |
Verapamil, diltiazem. bepridil
|
|
Antiarrhythmics
Class IV Mechanism |
Primarily affect AV nodal cells. ↓ conduction velocity, ↑ ERP, ↑ PR interval.
|
|
Antiarrhythmics
Class IV uses |
prevention of nodal arrhythmias (e.g., SVT).
|
|
Antiarrhythmics
Class IV toxicity |
Constipation, flushing, edema, CV effects (CHF, AV block, sinus node depression);
torsades de pointes (bepridil). |
|
Antiarrhythmics
misc names |
Adenosine
K+ Mg+ Digoxin |
|
misc antiarrhythmics
Adenosine |
Drug of choice in diagnosing/abolishing AV nodal arrhythmias.
|
|
misc antiarrhythmics
K+ |
Depresses ectopic pacemakers, especially in digoxin toxicity.
|
|
misc antiarrhythmics
Mg+ |
Effective in torsades de pointes and digoxin toxicity.
|
|
Effective in torsades de pointes and digoxin toxicity.
|
Mg+sulfate
|
|
Drug of choice in diagnosing and abolishing AV nodal arrhythmias.
|
Adenosine
|